Papers

3

Total Citations

63

H-Index

3

About

Dr. Amelia Jernigan is a leading figure in gynecologic oncology, with a focused research agenda on the comparative effectiveness of minimally invasive surgical platforms for treating endometrial cancer. Her most cited work, "Does surgical platform impact recurrence and survival?" (2019, 36 citations), provides critical evidence comparing multiport, single-port, and robotic-assisted laparoscopy, directly informing surgical decision-making to optimize patient outcomes. Dr. Jernigan has also contributed a comprehensive review of minimally invasive modalities (2012, 22 citations), synthesizing the field’s rapid evolution and highlighting the potential to reduce surgical morbidity. Her case report on iatrogenic uterine diverticulum after robotic myomectomy (2015) demonstrates her commitment to documenting rare complications, advancing surgical safety. With a career spanning over a decade, Dr. Jernigan’s work bridges technological innovation and clinical practice, offering surgeons and patients data-driven insights into the trade-offs of modern surgical approaches. Her research continues to shape the standard of care in gynecologic oncology, emphasizing both oncologic efficacy and quality of life.

Research Focus

Key Achievements

3
H-Index
3
Papers
63
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgery
36 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Case Western Reserve University, Johns Hopkins University, Cleveland Clinic

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago